A detailed history of Monaco Asset Management Sam transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 1,069,732 shares of EDIT stock, worth $2.05 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,069,732
Holding current value
$2.05 Million
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$1.2 - $3.76 $1.28 Million - $4.02 Million
1,069,732 New
1,069,732 $1.36 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $132M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.